Setipiprant
CAS: 866460-33-5
Ref. TM-T3520
10mg | 46.00 € | ||
25mg | 78.00 € | ||
50mg | 114.00 € | ||
100mg | 176.00 € | ||
200mg | 260.00 € | ||
1ml*10 (DMSO) | 35.00 € |
Product Information
- KYTH-105, ACT-129968
Setipiprant (ACT-129968) is an orally available, selective CRTH2 antagonist (IC50: 6.0 nM). CRTH2 is a G protein-coupled receptor for prostaglandin (PGD2). PGD2 is produced by the mast cells and is a key mediator in various inflammatory diseases, including allergy and asthma. Binding of PGD2 to CRTH2, which are expressed on the surface of blood-borne cells, induces chemotaxis of Th2 cells, basophils, and eosinophils, and stimulates cytokine release from these cells.
Chemical properties
Technical inquiry about: TM-T3520 Setipiprant
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.